Patients with irritable bowel syndrome (IBS) are often concerned that certain foods may trigger or worsen their symptoms, which can include abdominal pain, diarrhea, or constipation. In a new study, patients who ate rye bread ...
Jul 18, 2016
0
0
(HealthDay)—For adults with diabetic gastroparesis, relamorelin reduces vomiting frequency and severity and accelerates gastric emptying, according to a study published in the July issue of Gastroenterology.
Jul 7, 2016
0
6
Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.
Jun 6, 2016
0
26
'My stomach hurts!' It's probably the oldest trick in the book to try to get out of school, but for some children who have abdominal pain related to irritable bowel syndrome, or IBS, the pain is real and often interferes ...
Apr 12, 2016
0
5
For at least some groups of "emerging adults," sleep problems are a predictor of chronic pain and worsening pain severity over time, suggests a study in Pain, the official publication of the International Association for ...
Mar 31, 2016
0
2
In a new national survey of Crohn's disease patients, Health Union reveals that it was not uncommon for patients to see multiple healthcare professionals (HCPs), have numerous office visits, and endure multiple diagnostic ...
Mar 1, 2016
0
10
Acute mesenteric ischemia (AMI) can be successfully treated with endovascular therapy such as balloon angioplasty, according to research from the University of Eastern Finland. The study also found that AMI is a more common ...
Feb 25, 2016
0
0
(HealthDay)—For patients with uncomplicated diverticulitis, quality of life (QOL) and other patient-reported outcomes (PROs) are improved following laparoscopic surgery versus conservative treatment, according to a review ...
Feb 4, 2016
0
0
(HealthDay)—Halaven (eribulin mesylate) has been approved by the U.S. Food and Drug Administration as the first chemotherapy drug shown to improve survival in people with advanced liposarcoma.
Jan 29, 2016
0
1
(HealthDay)—Eluxadoline (Viberzi) for irritable bowel syndrome (IBS) with diarrhea seems to reduce symptoms for some patients for at least six months, according to research published in the Jan. 21 issue of the New England ...
Jan 22, 2016
0
0
